Joanne Wuensch
Stock Analyst at Citigroup
(4.31)
# 401
Out of 5,120 analysts
445
Total ratings
63.48%
Success rate
11.52%
Average return
Main Sectors:
Stocks Rated by Joanne Wuensch
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ISRG Intuitive Surgical | Maintains: Neutral | $635 → $590 | $496.73 | +18.78% | 19 | Jan 23, 2026 | |
| ABT Abbott Laboratories | Maintains: Buy | $155 → $140 | $109.41 | +27.96% | 23 | Jan 23, 2026 | |
| JNJ Johnson & Johnson | Maintains: Buy | $232 → $250 | $230.75 | +8.34% | 17 | Jan 22, 2026 | |
| PEN Penumbra | Downgrades: Neutral | $350 → $374 | $356.99 | +4.76% | 27 | Jan 16, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Neutral | $98 → $94 | $86.22 | +9.02% | 23 | Dec 11, 2025 | |
| SYK Stryker | Maintains: Buy | $455 → $420 | $368.14 | +14.09% | 15 | Dec 11, 2025 | |
| SGHT Sight Sciences | Maintains: Neutral | $5.5 → $9.1 | $6.44 | +41.30% | 14 | Dec 11, 2025 | |
| ITGR Integer Holdings | Maintains: Neutral | $69 → $75 | $85.55 | -12.33% | 9 | Dec 11, 2025 | |
| GKOS Glaukos | Maintains: Buy | $113 → $125 | $117.47 | +6.41% | 23 | Dec 11, 2025 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $83 → $88 | $80.11 | +9.85% | 8 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $62 → $75 | $71.25 | +5.26% | 8 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $101 | $82.65 | +22.20% | 22 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $16 → $22 | $20.09 | +9.51% | 21 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $75 → $77 | $72.53 | +6.16% | 17 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $77 → $88 | $65.78 | +33.78% | 10 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $72 → $88 | $80.65 | +9.11% | 22 | Dec 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $12 → $11 | $11.16 | -1.43% | 16 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $26 → $21 | $19.87 | +5.69% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $205 → $242 | $155.73 | +55.40% | 22 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $101 → $112 | $102.71 | +9.04% | 22 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $16.77 | -10.55% | 6 | Jul 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $6.5 → $4.15 | $1.63 | +154.60% | 12 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $320 → $380 | $256.62 | +48.08% | 16 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $119 → $125 | $91.87 | +36.06% | 35 | May 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $220 → $250 | $201.91 | +23.82% | 5 | Dec 12, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $67 → $69 | $79.38 | -13.08% | 5 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $109 → $127 | $254.74 | -50.15% | 6 | Dec 10, 2018 |
Intuitive Surgical
Jan 23, 2026
Maintains: Neutral
Price Target: $635 → $590
Current: $496.73
Upside: +18.78%
Abbott Laboratories
Jan 23, 2026
Maintains: Buy
Price Target: $155 → $140
Current: $109.41
Upside: +27.96%
Johnson & Johnson
Jan 22, 2026
Maintains: Buy
Price Target: $232 → $250
Current: $230.75
Upside: +8.34%
Penumbra
Jan 16, 2026
Downgrades: Neutral
Price Target: $350 → $374
Current: $356.99
Upside: +4.76%
Zimmer Biomet Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $98 → $94
Current: $86.22
Upside: +9.02%
Stryker
Dec 11, 2025
Maintains: Buy
Price Target: $455 → $420
Current: $368.14
Upside: +14.09%
Sight Sciences
Dec 11, 2025
Maintains: Neutral
Price Target: $5.5 → $9.1
Current: $6.44
Upside: +41.30%
Integer Holdings
Dec 11, 2025
Maintains: Neutral
Price Target: $69 → $75
Current: $85.55
Upside: -12.33%
Glaukos
Dec 11, 2025
Maintains: Buy
Price Target: $113 → $125
Current: $117.47
Upside: +6.41%
GE HealthCare Technologies
Dec 11, 2025
Maintains: Neutral
Price Target: $83 → $88
Current: $80.11
Upside: +9.85%
Dec 11, 2025
Maintains: Neutral
Price Target: $62 → $75
Current: $71.25
Upside: +5.26%
Dec 11, 2025
Maintains: Buy
Price Target: $96 → $101
Current: $82.65
Upside: +22.20%
Dec 11, 2025
Maintains: Neutral
Price Target: $16 → $22
Current: $20.09
Upside: +9.51%
Dec 11, 2025
Maintains: Buy
Price Target: $75 → $77
Current: $72.53
Upside: +6.16%
Dec 11, 2025
Downgrades: Neutral
Price Target: $77 → $88
Current: $65.78
Upside: +33.78%
Dec 8, 2025
Maintains: Neutral
Price Target: $72 → $88
Current: $80.65
Upside: +9.11%
Oct 31, 2025
Maintains: Sell
Price Target: $12 → $11
Current: $11.16
Upside: -1.43%
Oct 31, 2025
Maintains: Neutral
Price Target: $26 → $21
Current: $19.87
Upside: +5.69%
Oct 31, 2025
Maintains: Buy
Price Target: $205 → $242
Current: $155.73
Upside: +55.40%
Oct 7, 2025
Maintains: Buy
Price Target: $101 → $112
Current: $102.71
Upside: +9.04%
Jul 9, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $16.77
Upside: -10.55%
May 22, 2025
Maintains: Neutral
Price Target: $6.5 → $4.15
Current: $1.63
Upside: +154.60%
May 22, 2025
Maintains: Buy
Price Target: $320 → $380
Current: $256.62
Upside: +48.08%
May 22, 2025
Maintains: Buy
Price Target: $119 → $125
Current: $91.87
Upside: +36.06%
Dec 12, 2022
Upgrades: Neutral
Price Target: $220 → $250
Current: $201.91
Upside: +23.82%
Nov 17, 2022
Maintains: Neutral
Price Target: $67 → $69
Current: $79.38
Upside: -13.08%
Dec 10, 2018
Upgrades: Outperform
Price Target: $109 → $127
Current: $254.74
Upside: -50.15%